United States News Todas as matérias

ArcelorMittal (NYSE:MT) said a missile strike hit its Kryvyi Rih steel operation in Ukraine, killing two people, injuring 13 and partially halting production.

HUTCHMED (NASDAQ:HCM) reported that ORPATHYS plus TAGRISSO significantly improved progression-free and overall survival versus platinum-based chemotherapy in its 338-patient Phase 3 SAFFRON trial.

Mesoblast (NASDAQ:MESO) completed treatment of 350 patients in its pivotal Phase 3 MSB-DR004 trial of rexlemestrocel-L for chronic low back pain caused by degenerative disc disease.

Endeavour Silver (NYSE:EXK) temporarily suspended operations at its Terronera silver-gold mine in Jalisco, Mexico, after a community blockade began on August 12.

Genco Shipping & Trading (NYSE:GNK) defended its $27.50-per-share cash framework after Diana Shipping (NYSE:DSX) withdrew its offer to acquire the remaining Genco shares.

argenx (NASDAQ:ARGX) reported that subcutaneous VYVGART Hytrulo met the Phase 3 ALKIVIA primary endpoint, producing a 15.4-point greater mean Total Improvement Score than placebo at Week 52.

HIVE Digital Technologies (NASDAQ:HIVE), through BUZZ High Performance Computing, signed a five-year GPU cloud services agreement worth approximately $350 million with an investment-grade enterprise customer.

AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo said Enhertu significantly improved progression-free survival versus standard first-line treatment for advanced HER2-mutant non-small cell lung cancer.

• Cisco Systems (NASDAQ:CSCO) reported FY 2026 revenue of $63.3 billion, up 12%, as AI infrastructure orders reached $9.3 billion.
• Arista, HPE, Dell and Ciena are also reporting higher networking or AI infrastructure sales as data-center spending expands.
• The next phase depends on sustained AI infrastructure demand, product execution, supply availability and competition across networking architectures.

• Super Micro Computer (NASDAQ:SMCI) reported fiscal Q4 2026 net sales of $11.1 billion, up about 91% year over year, driven by demand for AI server infrastructure.
• The company reported net income of $1.18 billion, a gross margin of 17.5%, and fiscal 2026 sales of $39.1 billion.
• AI infrastructure companies are expanding production capacity while managing supply constraints, capital requirements, and demand for high-performance computing systems.

• CoreWeave (NASDAQ:CRWV) reported Q2 2026 revenue of $2.58 billion, more than doubling year over year, with revenue backlog reaching approximately $104 billion.
• The company reported adjusted EBITDA of $1.51 billion, while GAAP net loss widened to about $626 million as infrastructure investment continued.
• AI cloud providers are expanding computing capacity through financing, customer partnerships, and specialized infrastructure while managing high capital requirements.

• Tapestry (NYSE:TPR) reported fiscal 2026 revenue of $8 billion, up 14%, as Coach revenue increased 24% for the year.
• Ralph Lauren is also posting double-digit growth, while Capri and LVMH’s Fashion & Leather Goods business show a more mixed sales picture.
• The sector now faces uneven consumer demand, tariffs, currency movements and pressure to protect margins while maintaining brand growth.

Tvardi Therapeutics (NASDAQ:TVRD) reported a Q2 2026 net loss of $6.5 million as R&D spending declined to $4 million.

PowerCompute (NASDAQ:PWCM) reported second-quarter revenue of $2.12 million, up 9.8% year over year, as Bitcoin production increased to 27.9 BTC.

Neumora Therapeutics (NASDAQ:NMRA) reported a Q2 2026 net loss of $43.1 million, narrowing from $52.7 million a year earlier.

Outlook Therapeutics (NASDAQ:OTLK) reported a fiscal Q3 net loss of $20.3 million as it prepares to launch FDA-approved wet AMD treatment LYTENAVA.

Teamshares (NASDAQ:TMS) reported second-quarter revenue of $148.7 million, up 20%, while net income improved to $9.5 million from a $12.9 million loss.

Super League (NASDAQ:SLE) reported Q2 gross revenue of approximately $3 million, while net revenue rose 16% sequentially to $1.24 million.

Edible Garden (NASDAQ:EDBL) reported second-quarter revenue of $3.6 million, up 12.8%, while total sales increased 31.2% year over year.

Beneficient (NASDAQ:BENF) reported fiscal Q1 2027 GAAP revenue of $12.2 million and an operating loss of $0.4 million as expenses declined sharply.

MySize (NASDAQ:MYSZ) reported second-quarter revenue of $3.07 million, up 53% year over year, while net loss widened to $1.75 million.

Boost Run (NASDAQ:BRUN) reported Q2 revenue of $31.1 million, up 270%, while total long-term contracted revenue reached $1.9 billion.

SurgePays (NASDAQ:SURG) reported Q2 revenue of $16.2 million, up 40.7%, while net income available to common stockholders reached $1.29 million.

TuHURA Biosciences (NASDAQ:HURA) ended Q2 2026 with $1 million in cash as R&D spending rose to $6.6 million amid increased clinical activity.